Cryopreservation Should Be Encouraged Prior to Cancer Treatment

Researchers have found that preserving sperm prior to cancer treatment significantly boosts the odds of men being able to have children after treatment.

The research, conducted at the University Medical Centre in Groningen, identified 334 survivors of Hodgkin's lymphoma who underwent treatment for the disease between 1974 and 2004 and who desired children after treatment.

A significant impact on conception

The retrospective study found that freezing their sperm – cryopreservation – literally doubled their chances of having children afterwards, compared to those who did not freeze sperm. Of those men who underwent cryopreservation, a full 62 percent were able to have children.

According to researcher Dr. Marleen van der Kaaij:

Our study shows that cryopreservation of semen before cancer treatment has a large impact: one in five children born after Hodgkin's lymphoma treatment was born using cryopreserved semen, Cryopreservation should always be offered to all male patients about to undergo cancer treatment – even in situations where treatment should start urgently or where first-line treatment is not very toxic to fertility. Clinicians should [realize] the enormous impact of this cheap and simple procedure.

Notable findings

Other findings included the following:

  • Chemotherapy was a motivating factor, with those receiving chemo being four times more likely to have cryopreservation.
  • Men under 30 and men with higher education levels were more likely to freeze their sperm.
  • The practice has grown increasingly common, with the numbers of men undergoing cryopreservation before treatment increasing exponentially every decade or so.
  • A full 23 percent of these men were unable to conceive naturally.

Researchers hope that these findings, published in the journal Human Reproduction, will encourage doctors to encourage their male patients to undergo cryopreservation if they have any inkling that the men may want children after cancer treatment.

Source: Human Reproduction

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap